<DOC>
	<DOCNO>NCT00289198</DOCNO>
	<brief_summary>The primary objective study compare efficacy safety GW685698X 100mcg daily ( QD ) aqueous nasal spray vehicle placebo nasal spray adult adolescent subject ( 12 year age old ) perennial allergic rhinitis ( PAR ) .</brief_summary>
	<brief_title>Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis ( PAR )</brief_title>
	<detailed_description>A Randomized , Double-Blind , Placebo-Controlled , Parallel-Group , Multicenter Study Evaluate Efficacy Safety Once-Daily Intranasal Administration GW685698X Aqueous Nasal Spray 100mcg 6 Weeks Adult Adolescent Subjects 12 year Age Older Perennial Allergic Rhinitis ( PAR )</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Diagnosis perennial allergic rhinitis ( PAR ) . Must comply study procedure literate . Significant concomitant medical condition . Use corticosteroid . Use allergy identify medication study . Current tobacco use tobacco use within past year . Exposure investigational study drug within past 12 month . Clinically significant abnormal electrocardiogram ( ECG ) laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>GW685698X</keyword>
	<keyword>perennial allergic rhinitis</keyword>
	<keyword>allergic rhinitis</keyword>
</DOC>